Tainuo Maibo

An innovative biopharmaceutical company focused on the research and development of novel natural fully human monoclonal antibody drugs, utilizing its proprietary HitmAb technology platform

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical development

Model

01Company Overview

An innovative biopharmaceutical company focused on the research and development of novel natural fully human monoclonal antibody drugs, utilizing its proprietary HitmAb technology platform.

02Backed By1 investor

GVGL Ventures→

03Similar Companies